FLGT
Fulgent Genetics Inc.
Company Overview
| Mkt Cap | $687.72M | Price | $23.11 |
| Volume | 304.52K | Change | +2.94% |
| P/E Ratio | -16.1 | Open | $22.46 |
| Revenue | $283.5M | Prev Close | $22.45 |
| Net Income | $-42.7M | 52W Range | $14.57 - $24.64 |
| Div Yield | N/A | Target | $25.33 |
| Overall | 63 | Value | 60 |
| Quality | 55 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyFulgent Genetics Inc. (FLGT) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $23.11 with a market capitalization of $687.72 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating average quality indicators with a MarketXLS quality score of 55.
Today's trading session shows FLGT with a volume of 305K shares. The stock opened up 0.04% from yesterday's close of $22.45. Current analyst estimates project earnings of $-1.64 per share for this year, with next year targeting $-1.98.
FLGT demonstrates strong technical indicators based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including PAVM, PECN, PEYE, PACB.
Key investment considerations for FLGT include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 9.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 4, 2025 at 08:09 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FLGT | $23.11 | +2.9% | 304.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |